| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 42, 1140-1146, Copyright © 1996 by American Association for Clinical Chemistry
HK Jensen, LG Jensen, PS Hansen, O Faergeman and N Gregersen
Center for Medical Molecular Biology, Aarhus University Hospital, Skejby Sygehus, Denmark. hkj@aas.arhusamt.dk
We designed oligonucleotide primer pairs to amplify the promoter region, the translated exon sequences, and the flanking intron sequences of all 18 exons of the LDL receptor gene to compare the ability of the PCR single-strand conformation polymorphism (PCR-SSCP) method with semiautomated solid-phase genomic DNA sequencing to detect sequence variations. In 20 apparently unrelated Danish patients with a clinical diagnosis of heterozygous familial hypercholesterolemia (FH), we identified 13 different mutations in the LDL receptor gene: two silent (C331C, N494 N); five missense (W66G, E119K, T383P, W556S, T7051); one nonsense (W23X); three splice-site (313 + 1G-->A, 1061-8T-- >C, 1846-1G-->A); and two frameshift (335del10, 1650delG) mutations. Four of these mutations, N494 N, T383P, 1061-8T-->C, and W556S, have not been reported earlier. The pathogenicity of the T383P, 1061-8T-->C, and W556S mutations remains to be established by in vitro mutagenesis and transfection studies. One patient had three mutations (335del10, 1061-8T-->C, and T705I) on the same allele. Further, nine well-known polymorphisms were detectable with this methodological setup. Direct DNA sequencing of the PCR products used for the SSCP analysis did not reveal any sequence variations not detected by the PCR-SSCP method. In two patients we did not detect any mutation by either method. We conclude that the PCR-SSCP analysis, performed as described here, is as sensitive and efficient as DNA sequencing in the ability to identify the sequence variations in the LDL receptor gene of the patients with heterozygous FH of this study.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  S E Humphries, R A Whittall, C S Hubbart, S Maplebeck, J A Cooper, A K Soutar, R Naoumova, G R Thompson, M Seed, P N Durrington, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk J. Med. Genet., December 1, 2006; 43(12): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Alharbi, M. A. Aldahmesh, E. Spanakis, L. Haddad, R. A. Whittall, X.-h. Chen, H. Rassoulian, M. J. Smith, J. Sillibourne, N. J. Ball, et al. Mutation scanning by meltMADGE: Validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population Genome Res., July 1, 2005; 15(7): 967 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Chang, J.-P. Pan, D.-Y. Tai, A.-C. Huang, P.-H. Li, H.-L. Ho, H.-L. Hsieh, S.-C. Chou, W.-L. Lin, E. Lo, et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese J. Lipid Res., October 1, 2003; 44(10): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Tai, E. S.C. Koay, E. Chan, T. J. Seng, L. M. Loh, S. K. Sethi, and C. E. Tan Compound Heterozygous Familial Hypercholesterolemia and Familial Defective Apolipoprotein B-100 Produce Exaggerated Hypercholesterolemia Clin. Chem., March 1, 2001; 47(3): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E HEATH, R. A WHITTALL, G. J MILLER, and S. E HUMPHRIES I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels J. Med. Genet., September 1, 2000; 37(9): 713 - 715. [Full Text]
|
|
|
|
|
|
R. Thiart, C. L Scholtz, J. Vergotine, C. F Hoogendijk, J N. P de Villiers, H. Nissen, K. Brusgaard, D. Gaffney, M. S Hoffs, W J H. Vermaak, et al. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia J. Med. Genet., July 1, 2000; 37(7): 514 - 519. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. von Kodolitsch, R. E. Pyeritz, and P. K. Rogan Splice-Site Mutations in Atherosclerosis Candidate Genes : Relating Individual Information to Phenotype Circulation, August 17, 1999; 100(7): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bertolini, S. Cassanelli, R. Garuti, M. Ghisellini, M. L. Simone, M. Rolleri, P. Masturzo, and S. Calandra Analysis of LDL Receptor Gene Mutations in Italian Patients With Homozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 408 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-T. Mak, C.-P. Pang, B. Tomlinson, J. Zhang, Y.-S. Chan, T. W. L. Mak, and J. R. L. Masarei Mutations in the Low-Density Lipoprotein Receptor Gene in Chinese Familial Hypercholesterolemia Patients Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1600 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Esposito, R. Palmirotta, M. C. Veri, S. Mammarella, F. D'Amico, M. C. Curia, G. Aceto, S. Crognale, B. Creati, R. Mariani-Costantini, et al. Optimized PCR labeling in mutational and microsatellite analysis Clin. Chem., July 1, 1998; 44(7): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Raungaard, F. Heath, J. U. Brorholt-Petersen, H. K. Jensen, and O. Faergeman Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia Clin. Chem., May 1, 1998; 44(5): 966 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Henderson, P. R. Wenham, J. P. Ashby, and G. Blundell Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared Clin. Chem., September 1, 1997; 43(9): 1630 - 1634. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
